Status:

UNKNOWN

Comparison Between Percutaneous Femoral Nerve Neuromodulation Associated With Femoral Nerve Block and Standard Clinical Practice in Patients Undergoing Knee Arthroplasty.

Lead Sponsor:

Hospital General Universitario de Valencia

Conditions:

Acute Pain

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The goal of this clinical trial is to compare the maximum isometric contraction force differential of the quadriceps in the postoperative period after the use of a peripheral nerve neuromodulation pro...

Eligibility Criteria

Inclusion

  • Over 18 years
  • Those who sign the informed consent
  • Not pregnant
  • Cognitive capacity that allows subjective postoperative evaluations.

Exclusion

  • Under 18 years old
  • IC rejection or withdrawal
  • Pregnancy
  • Cognitive impairment
  • Contraindication for Regional Anesthesia

Key Trial Info

Start Date :

June 1 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

May 1 2024

Estimated Enrollment :

64 Patients enrolled

Trial Details

Trial ID

NCT05971095

Start Date

June 1 2023

End Date

May 1 2024

Last Update

August 2 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hospital General Universitario de Valencia

Valencia, Spain, 46020

Comparison Between Percutaneous Femoral Nerve Neuromodulation Associated With Femoral Nerve Block and Standard Clinical Practice in Patients Undergoing Knee Arthroplasty. | DecenTrialz